p38 Mitogen-activated protein kinase inhibitors: a review on pharmacophore mapping and QSAR studies

RP Gangwal, A Bhadauriya, MV Damre… - Current topics in …, 2013 - ingentaconnect.com
p38 mitogen-activated protein (MAP) kinases are the serine/threonine protein kinases,
which play a vital role in cellular responses to external stress signals. p38 MAP kinase …

The discovery of (R)-2-(sec-butylamino)-N-(2-methyl-5-(methylcarbamoyl) phenyl) thiazole-5-carboxamide (BMS-640994)—A potent and efficacious p38α MAP kinase …

J Hynes Jr, H Wu, S Pitt, DR Shen, R Zhang… - Bioorganic & medicinal …, 2008 - Elsevier
A novel structural class of p38α MAP kinase inhibitors has been identified via iterative SAR
studies of a focused deck screen hit. Optimization of the lead series generated 6e, BMS …

Successful structure-based design of recent p38 MAP kinase inhibitors

SC Karcher, SA Laufer - Current Topics in Medicinal Chemistry, 2009 - ingentaconnect.com
Inflammation is a complex immune response to cellular and tissue damage caused by
physical, chemical, immunological, or microbial stimuli [1]. Prior to the successful launch of …

Current insights of inhibitors of p38 mitogen-activated protein kinase in inflammation

A Awasthi, MB Raju, MA Rahman - Medicinal Chemistry, 2021 - ingentaconnect.com
Background: The inflammatory process is one of the mechanisms by which our body
upholds us from pathogens such as parasites, bacteria, viruses, and other harmful …

[HTML][HTML] Structure-based virtual screening for novel p38 MAPK inhibitors and a biological evaluation

Q Zheng, Y Zhu, A Wang, P Yang, X Wang… - Acta Materia …, 2023 - ucl.scienceopen.com
Mitogen-activated protein kinases (MAPKs) are a group of serine-threonine protein kinases
that can be activated by extracellular stimuli. MAPK14 (p38α) affects major disease …

Small molecule p38 MAP kinase inhibitors for the treatment of inflammatory diseases: novel structures and developments during 2006-2008

LH Pettus, RP Wurz - Current topics in medicinal chemistry, 2008 - ingentaconnect.com
The p38 mitogen-activated protein (MAP) kinase plays a central role in inflammation. It has
been the subject of extensive efforts in both basic research and drug discovery for the …

Structure-based virtual screening approach to the discovery of p38 MAP kinase inhibitors

H Choi, HJ Park, JC Shin, HS Ko, JK Lee, S Lee… - Bioorganic & medicinal …, 2012 - Elsevier
p38 Mitogen-activated protein kinase (MAPK) has been considered to be a promising target
for the development of therapeutics for various immunologic diseases. Herein we report an …

Molecular basis for p38 protein kinase inhibitor specificity

JM Lisnock, A Tebben, B Frantz, EA O'Neill, G Croft… - Biochemistry, 1998 - ACS Publications
p38 is a member of the mitogen-activated protein (MAP) kinase family and is a critical
enzyme in the proinflammatory cytokine pathway. Other MAP kinase group members that …

Amide-based inhibitors of p38α MAP kinase. Part 1: Discovery of novel N-pyridyl amide lead molecules

GR Luedtke, K Schinzel, X Tan, RW Tester… - Bioorganic & Medicinal …, 2010 - Elsevier
A novel series of N-pyridyl amides as potent p38α kinase inhibitors is described. Based on
the structural similarities between the initial hit and a well-known imidazole pyrimidine series …

Virtual screening based on pharmacophore model followed by docking simulation studies in search of potential inhibitors for p38 map kinase

M Shahlaei, E Doosti - Biomedicine & Pharmacotherapy, 2016 - Elsevier
P38 mitogen-activated protein (MAP) kinase inhibitors are closely involved in the production
of inflammatory cytokines. These compounds are considered promising therapeutic agents …